Generate Biomedicines, Inc. Common Stock (GENB)

Generate Biomedicines, Inc. Common Stock (GENB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.8B; returns 1 day -3.0%, 1 week +2.6%.

Generate Biomedicines (GENB) is a clinical-stage generative biology company that leverages artificial intelligence and machine learning to design and develop novel protein therapeutics.

Groups GENB belongs to

• Clinical Stage Biotech
• Recent IPOs
• Biotechnology
• Artificial Intelligence
• Drug Discovery
• Machine Learning
• Biopharmaceutical
• AI in Healthcare
• Monoclonal Antibodies
• Healthcare Technology
• Oncology

GENB financial model: income statement, cash flow and balance sheet